Clinical Trial Update: A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth [Phase 2]

View source ↗

Summary

Phase 2 study evaluating OBE001 versus placebo to delay preterm birth has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• OBE001

Snippet

Sponsor: ObsEva SA | Conditions: Preterm Labor | Phase 2 | Status: TERMINATED